期刊文献+

MMP-9和PEDF在胃癌侵袭转移中的作用 被引量:1

Expressions of MMP-9 and PEDF and their correlation with tumor invasion and lymph node metastasis in gastric carcinoma
下载PDF
导出
摘要 目的探讨基质金属蛋白酶9(matrix metalloproteinase 9,MMP-9)和色素上皮源性因子(pigmentepithelium-derived factor,PEDF)基因表达在胃癌侵袭转移中的作用,为防治胃癌转移提供理论依据。方法应用免疫组织化学法检测82例人体胃癌组织标本中胃癌细胞内MMP-9和PEDF的表达;统计学分析两种分子标记物与胃癌侵袭转移关系。结果胃癌组织中的MMP-9和PEDF表达率分别约为70%和43%,MMP-9高表达和PEDF低表达与浸润深度、淋巴管转移和远处转移呈正相关(P<0.05);MMP-9与PEDF表达呈负相关(P<0.01)。结论MMP-9在胃癌侵袭转移中起促进作用,PEDF可抑制胃癌的进展,PEDF低表达可能通过上调MMP-9的表达从而促进胃癌的侵袭转移。 Objective To investigate the expressions of Matrix Metalloproteinase 9 (MMP- 9) and Pigment epithelium - derived factor (PEDF) and their correlation with ttanor invasion and metastasis in human gastric carcinoms, Methods Immunohistochemistry method was used to detect the expressions of MMP- 9 and PEDF in 82 eases of gastric carcinoma tissue samples. The relationship between the molecular markers and tumor invasion and metastasis were analyzed. Results The expression rates of MMP - 9 and PEDF were 70% and 43% respectively in gastric carcinoma patients. MMP - 9 expression was related to depth of invasion and lymph node metastasis as well as distant metastasis. Low PEDF protein expression was significantly associated with tumor- increased penetration through the gastric wall, lymph node and distant metastasis. There was negative correlation between the expression of MMP- 9 and PEDF. Conclusion MMP- 9 can accelerate the development and progression of gastric carcinoma, while PEDF play a negative role in tumor progression. The low expression of PEDF may promote the tumor invasion by upregulating the expression of MMP- 9,
出处 《广东医学》 CAS CSCD 北大核心 2006年第10期1468-1470,共3页 Guangdong Medical Journal
基金 广东省自然科学基金资助项目(编号:05001748) 教育部留学回国人员科研启动基金项目(编号:2004A128)
关键词 胃肿瘤 基质金属蛋白酶9 色素上皮源性因子 侵袭转移 Gastric neoplasm Matrix metalloproteinase 9 Pigment epithelium- derived factor Tumor invasion and metastasis
  • 相关文献

参考文献1

二级参考文献1

共引文献25

同被引文献15

  • 1李军川,陈廷煊.非小细胞肺癌中伴神经内分泌分化及c-erbB-2表达的意义[J].肿瘤防治研究,2005,32(1):22-23. 被引量:1
  • 2ZHANG X,ZHU S,LUO G,et al.Expression of MMP-10 in lung cancer[J].Anticancer Res,2007,27(4C):2791-2795.
  • 3FREDERICK L A,MATTHEWS J A,JAMIESON L,et al.Matrix metalloproteinase-10 is a critical effector of protein kinase Ciota-Par6alpha-mediated lung cancer[J].Oncogene,2008,27(35):4841-4853.
  • 4NAKAMURA H,KAWASAKI N,TAGUCHI M,et al.Association of HER-2 overexpression with prognosis in nonsmall cell lung carcinoma:a metaanalysis[J].Cancer,2005,103(9):1865-1873.
  • 5SELVAGGI G,SCAGLIOTTI G V,TORRI V,et al.HER-2/neu overexpression in patients with radically resected nonsmall cell lung carcinoma.Impact on long-term survival[J].Cancer,2002,94(10):2669-2674.
  • 6HIRSCH F R,LANGER C J.The role of HER2/neu expression and trastuzumab in non-small cell lung cancer[J].Semin Oncol,2004,31(1 Suppl 1):75-82.
  • 7GATZEMEIER U,GROTH G,BUTTS C,et al.Randomized phase II trial of gemcitabine-cisplatin with or without trastuzumab in HER2-positive non-small-cell lung cancer[J].Ann Oncol,2004,15(1):19-27.
  • 8NAKAMURA H,FUJII Y,OHUCHI E,et al.Activation of the precursor of human stromelysin 2 and its interactions with other matrix metalloproteinases[J].Eur J Biochem,1998,253(1):67-75.
  • 9THORNS C,BERND H W,HATTON D,et al.Matrix-metalloproteinases in Hodgkin lymphoma[J].Anticancer Res,2003,23(2B):1555-1558.
  • 10MIYATA Y,IWATA T,MARUTA S,et al.Expression of matrix metalloproteinase-10 in renal cell carcinoma and its prognostic role[J].Eur Urol,2007,52(3):791-797.

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部